Abstract
Pyridine-2-azo-p-dimethylaniline cephalosporin (PADAC), a chromogenic reagent which is purple and changes to yellow upon cleavage of its .beta.-lactam ring, was evaluated in comparison with other chromogenic cephalosporins. PADAC exhibited little antimicrobial activity against gram-negative bacteria, but did have good activity (minimum inhibitory concentration [MIC], 0.12-0.5 .mu.g/ml) against Staphylococcus aureus, a quality comparable to nitrocefin. Nitrocefin however demonstrated an unexpected and uniquely potent activity against Streptococcus faecalis (MIC, .ltoreq. 0.06 to 0.12 .mu.g/ml). The relative hydrolysis rate of PADAC when subjected to 6 different .beta.-lactamases was substantially greater than that of cephacetrile, but less than that of nitrocefin. The relative hydrolysis rates of PADAC and nitrocefin were comparable with type IIIa .beta.-lactamase and that derived from Bacillus cereus. The inhibition of .beta.-lactamase hydrolysis of the chromogenic cephalosporin substrates by 6 enzyme-stable inhibitors was generally greater with PADAC than with nitrocefin. Unlike nitrocefin, PADAC mixed with 50% human serum or various broth culture media showed no evidence of color change or degradation over several hours. The subsequent enzyme hydrolysis rates of such mixtures were the same as in phosphate buffer. .beta.-Lactamase-containing bacterial suspensions and clinical specimens containing such bacteria produced positive visual and spectrophotometric color changes when mixed with PADAC or nitrocefin. Although color changes occurred more slowly with PADAC than with nitrocefin, PADAC was not adversely influenced (non-enzyme-related color change) by the protein content of specimens. PADAC appears to be a promising alternative for .beta.-lactamase diagnostic testing in the clinical and research microbiology laboratory.